News Moderna’s Capabilities Beyond Covid-19 Vaccines are Underappreciated UBS analyst Eliana Merle has upgraded shares of biotech company Moderna to Buy from Neutral, attributing the move to investors’ lack of appreciation ... By Artur FernandoJune 30, 20230
Novo Nordisk and Valo Health Collaborate to Develop Treatments for Cardiometabolic Diseases 1 hour ago